114 related articles for article (PubMed ID: 3446772)
1. Host-mediated antitumor effect of grifolan NMF-5N, a polysaccharide obtained from Grifola frondosa.
Takeyama T; Suzuki I; Ohno N; Oikawa S; Sato K; Ohsawa M; Yadomae T
J Pharmacobiodyn; 1987 Nov; 10(11):644-51. PubMed ID: 3446772
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of polysaccharide grifolan NMF-5N on syngeneic tumor in mice.
Suzuki I; Takeyama T; Ohno N; Oikawa S; Sato K; Suzuki Y; Yadomae T
J Pharmacobiodyn; 1987 Feb; 10(2):72-7. PubMed ID: 3598845
[TBL] [Abstract][Full Text] [Related]
3. Distribution of grifolan NMF-5N (I/B), a chemically modified antitumor beta-glucan in mice.
Takeyama T; Suzuki I; Ohno N; Oikawa S; Sato K; Ohsawa M; Yadomae T
J Pharmacobiodyn; 1988 Jun; 11(6):381-5. PubMed ID: 3171879
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a beta-1,3-glucan obtained from liquid cultured mycelium of Grifola frondosa.
Ohno N; Adachi Y; Suzuki I; Oikawa S; Sato K; Ohsawa M; Yadomae T
J Pharmacobiodyn; 1986 Oct; 9(10):861-4. PubMed ID: 3820062
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta-glucans on the nitric oxide synthesis by peritoneal macrophage in mice.
Ohno N; Egawa Y; Hashimoto T; Adachi Y; Yadomae T
Biol Pharm Bull; 1996 Apr; 19(4):608-12. PubMed ID: 8860968
[TBL] [Abstract][Full Text] [Related]
6. Physiochemical properties and antitumor activities of chemically modified derivatives of antitumor glucan "grifolan LE" from Grifola frondosa.
Adachi Y; Ohno N; Ohsawa M; Sato K; Oikawa S; Yadomae T
Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1838-43. PubMed ID: 2805163
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of host-mediated antitumor activity by a beta-glucan derived from mycelia of Cochliobolus miyabeanus.
Nanba H; Kuroda H
Chem Pharm Bull (Tokyo); 1987 Apr; 35(4):1523-30. PubMed ID: 3652293
[No Abstract] [Full Text] [Related]
8. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H
Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601
[TBL] [Abstract][Full Text] [Related]
9. Relationship between solubility of grifolan, a fungal 1,3-beta-D-glucan, and production of tumor necrosis factor by macrophages in vitro.
Ishibashi K; Miura NN; Adachi Y; Ohno N; Yadomae T
Biosci Biotechnol Biochem; 2001 Sep; 65(9):1993-2000. PubMed ID: 11676011
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cytokine production by macrophages stimulated with (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa.
Adachi Y; Okazaki M; Ohno N; Yadomae T
Biol Pharm Bull; 1994 Dec; 17(12):1554-60. PubMed ID: 7537572
[TBL] [Abstract][Full Text] [Related]
11. Modification of immunostimulating activities of grifolan by the treatment with (1----3)-beta-D-glucanase.
Nono I; Ohno N; Ohsawa M; Oikawa S; Yadomae T
J Pharmacobiodyn; 1989 Nov; 12(11):671-80. PubMed ID: 2632764
[TBL] [Abstract][Full Text] [Related]
12. Oxidative degradation of an antitumor (1-3)-beta-D-glucan, grifolan.
Nono I; Ohno N; Masuda A; Oikawa S; Yadomae T
J Pharmacobiodyn; 1991 Jan; 14(1):9-19. PubMed ID: 1907324
[TBL] [Abstract][Full Text] [Related]
13. Antitumor and immunomodulating activities of a beta-glucan obtained from liquid-cultured Grifola frondosa.
Suzuki I; Hashimoto K; Oikawa S; Sato K; Osawa M; Yadomae T
Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):410-3. PubMed ID: 2743484
[TBL] [Abstract][Full Text] [Related]
14. Preparation and antigen specificity of an anti-(1-->3)-beta-D-glucan antibody.
Adachi Y; Ohno N; Yadomae T
Biol Pharm Bull; 1994 Nov; 17(11):1508-12. PubMed ID: 7703974
[TBL] [Abstract][Full Text] [Related]
15. The effects of a highly branched beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic tumors in mice.
Suzuki I; Hashimoto K; Yadomae T
J Pharmacobiodyn; 1988 Aug; 11(8):527-32. PubMed ID: 3236210
[TBL] [Abstract][Full Text] [Related]
16. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H
J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor.
Masuda Y; Nakayama Y; Tanaka A; Naito K; Konishi M
PLoS One; 2017; 12(3):e0173621. PubMed ID: 28278221
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1-->3)-beta-D-glucans in mice.
Ohno N; Asada N; Adachi Y; Yadomae T
Biol Pharm Bull; 1995 Jan; 18(1):126-33. PubMed ID: 7735226
[TBL] [Abstract][Full Text] [Related]
19. Modulation of antitumor activity of grifolan by subsequent administration of (1----3)-beta-D-glucanase in vivo.
Nono I; Ohno N; Ohsawa M; Oikawa S; Yadomae T
J Pharmacobiodyn; 1989 Oct; 12(10):581-8. PubMed ID: 2517127
[TBL] [Abstract][Full Text] [Related]
20. Effect of grifolan on the ascites form of Sarcoma 180.
Ohno N; Suzuki Y; Sato K; Oikawa S; Yadomae T
Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2576-80. PubMed ID: 3664853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
